Veterinary Union Pharmacovigilance Database - Best Practice Guide

Veterinary signal assessment report for marketing authorisation holders

Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Date of authorisation: 18/11/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Tuzodi, midazolam, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 37, Status: Authorised

Veterinary Scientific Advice procedure – timelines 2026 - information for applicants

Human medicines European public assessment report (EPAR): Sunitinib Accord, sunitinib, Date of authorisation: 11/02/2021, Revision: 4, Status: Authorised

Dengvaxia : EPAR - All authorised presentations

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 11:00 (CET) to 18 November 2025, 12:00 (CET)